安全和有效的抗凝药使用:抗凝药管理中的案例研究
Jori E May1, Arthur L Allen2, Bethany T Samuelson Bannow3
1Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Journal of thrombosis and haemostasis : JTH
|December 12, 2024
概括
抗凝血药物管理计划通过解决常见的挑战,如错误的剂量和管理副作用来提高患者的安全性和结果. 这些计划促进安全,有效和成本意识的药物使用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
- 患者安全 患者安全
背景情况:
- 抗凝血药物被广泛使用,但具有很高的不良事件风险.
- 护理缺口和低于最佳的药物使用需要改进的管理策略.
- 抗凝血管理已经成为优化患者护理的关键实践.
研究的目的:
- 突出抗凝固管理中的共同挑战.
- 展示展示这些挑战的案例研究.
- 为了证明抗凝固管理计划的好处.
主要方法:
- 复杂的抗凝血管理问题的4例患者病例的审查.
- 直接口服抗凝剂剂量错误的讨论.
- 探索肝素诱导的血小板缺血的诊断和管理.
- 对周围手术抗凝剂和针对严重月经出血的抗凝剂的分析.
- 检查成功的抗凝血管理计划模型.
主要成果:
- 直接口服抗凝剂的不适当剂量是一个常见的问题.
- 肝素诱导的血小板缺血需要仔细的诊断和管理.
- 周围程序性抗凝剂和管理出血风险存在重大挑战.
- 成功的管理计划可以有效地解决这些复杂的案例.
结论:
- 抗凝血药物管理对于安全有效的药物使用至关重要.
- 实施管理计划可以改善患者的治疗结果.
- 对抗凝血管理的投资优化了医疗保健资源的利用和患者的安全.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
Therapeutic Index
4.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
120
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Guidelines and Strategies for Safe Computer Charting
797
The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
Maintain Confidentiality and Security:
797


